Jeehae Park

Jeehae Park currently serves as a Senior Advisor at Eli Lilly and Company, bringing extensive experience in analytical research and development within the fields of gene therapy and cardiovascular disease. Previous roles include Principal Scientist at Verve Therapeutics and Intellia Therapeutics, where responsibilities encompassed high-throughput analytics, bioanalysis, and regulatory documentation. Notable achievements include the development of a new analytical platform for AAV gene therapy products at Sanofi, as well as contributions to mRNA expression modeling and biosensor engineering during postdoctoral positions at Harvard Medical School and Harvard University. Jeehae Park holds a Doctorate in Biophysics and Computational Biology from the University of Illinois Urbana-Champaign, alongside degrees in Bioengineering and Biology from Yonsei University and the University of Minnesota Morris, respectively.